glp-1 intestine Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes | SN Comprehensive Clinical Medicine GLP-1 and GLP-2 Orchestrate Intestine

Muscle carnitine deficiency in patients using valproic acid

11.1% of Participants Reported Using GLP-1s for More Than 18 Months 9.7% of users reported using GLP-1s for 1 month

Risk of serious side effects, including blood clots and ovarian hyperstimulation syndrome

Based on the findings, GLP-1 medications may benefit the cardiovascular and renal systems while also promoting weight loss, glycemic management, neurocognition, gut function, liver inflammation, alcohol use, and suicidal ideation

L., Rodbard, H

Association between pioglitazone use and prostate cancer: a population-based case-control study in the Han population